• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Reliability and applicability of movement disorder rating scales in the elderly.

作者信息

Sweet R A, DeSensi E G, Zubenko G S

机构信息

Department of Psychiatry, University of Pittsburgh School of Medicine, Pennsylvania.

出版信息

J Neuropsychiatry Clin Neurosci. 1993 Winter;5(1):56-60. doi: 10.1176/jnp.5.1.56.

DOI:10.1176/jnp.5.1.56
PMID:8428136
Abstract

Geriatric research clinicians were readily trained to use three scales initially developed for rating neuroleptic-induced movement disorders in mixed-age patients: the Abnormal Involuntary Movements Scale (AIMS), Simpson Extra Pyramidal Side Effect Scale (SEPSE), and Barnes Akathisia Scale (BAS). Interrater reliability, calculated by intraclass correlation coefficients, ranged from 0.79 to 0.93. Of elderly psychiatric inpatients tested, 97% were able to complete the examination, despite significant psychiatric, cognitive, and physical disabilities. AIMS, SEPSE, and BAS are reliable instruments for assessment of movement disorders in the elderly, representing an important first step in standardized evaluation of dyskinesia, parkinsonism, and akathisia in elderly psychiatric populations.

摘要

相似文献

1
Reliability and applicability of movement disorder rating scales in the elderly.
J Neuropsychiatry Clin Neurosci. 1993 Winter;5(1):56-60. doi: 10.1176/jnp.5.1.56.
2
The Schedule for the Assessment of Drug-Induced Movement Disorders (SADIMoD): test-retest reliability and concurrent validity.药物性运动障碍评估量表(SADIMoD):重测信度和同时效度
Int J Neuropsychopharmacol. 2000 Dec;3(4):285-296. doi: 10.1017/S1461145700002066.
3
Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations.抗精神病药相关运动障碍评估量表:系统评价、批判及推荐。
Mov Disord. 2023 Jun;38(6):1008-1026. doi: 10.1002/mds.29392. Epub 2023 Apr 20.
4
Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients.慢性精神分裂症住院患者中抗精神病药物所致运动障碍的患病率
Am J Psychiatry. 2004 Jan;161(1):160-3. doi: 10.1176/appi.ajp.161.1.160.
5
Diagnostic challenges revealed from a neuropsychiatry movement disorders clinic.神经精神病学运动障碍诊所揭示的诊断挑战。
Can J Neurol Sci. 2012 Nov;39(6):782-8. doi: 10.1017/s0317167100015614.
6
An interrater reliability study of the Braden scale in two nursing homes.在两家养老院对Braden量表进行的评分者间信度研究。
Int J Nurs Stud. 2008 Oct;45(10):1501-11. doi: 10.1016/j.ijnurstu.2008.02.007.
7
Assessment of extrapyramidal symptoms during acute neuroleptic treatment.急性抗精神病药物治疗期间锥体外系症状的评估。
J Clin Psychiatry. 1995 Mar;56(3):94-100.
8
Scale for evaluation of movement disorders in the first three years of life.
Pediatr Neurol. 2009 Apr;40(4):258-64. doi: 10.1016/j.pediatrneurol.2008.11.003.
9
Interrater reliability issues in multicenter trials, Part II: Statistical procedures used in Department of Veterans Affairs Cooperative Study #394.多中心试验中的评估者间可靠性问题,第二部分:退伍军人事务部合作研究#394中使用的统计程序。
Psychopharmacol Bull. 1997;33(1):59-67.
10
Validity and reliability of the Simpson-Angus Scale (SAS) in drug induced parkinsonism in the elderly.辛普森-安格斯量表(SAS)在老年药物性帕金森综合征中的有效性和可靠性。
Int J Geriatr Psychiatry. 2009 Feb;24(2):183-9. doi: 10.1002/gps.2091.

引用本文的文献

1
Quantification of motor abnormalities with instrumental tasks among adolescents with first-episode schizophrenia and depressive disorders.首次发作的精神分裂症和抑郁症青少年中通过仪器任务对运动异常进行量化。
Sci Rep. 2025 Jul 1;15(1):22151. doi: 10.1038/s41598-025-06590-w.
2
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.抗精神病药物相关运动障碍:药物性帕金森综合征与迟发性运动障碍——病理生理学和临床管理的关键差异
Neurol Ther. 2018 Dec;7(2):233-248. doi: 10.1007/s40120-018-0105-0. Epub 2018 Jul 19.
3
The Assessment and Treatment of Antipsychotic-Induced Akathisia.
抗精神病药物所致静坐不能的评估与治疗
Can J Psychiatry. 2018 Nov;63(11):719-729. doi: 10.1177/0706743718760288. Epub 2018 Apr 23.
4
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.阿立哌唑强化药物治疗对老年难治性抑郁症的疗效、安全性及耐受性:一项随机、双盲、安慰剂对照试验
Lancet. 2015 Dec 12;386(10011):2404-12. doi: 10.1016/S0140-6736(15)00308-6. Epub 2015 Sep 27.
5
Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.了解亨廷顿病药物试验中使用的疗效指标:一项系统综述。
J Huntingtons Dis. 2014;3(3):233-52. doi: 10.3233/JHD-140115.
6
Antipsychotic Adherence Intervention for Veterans over 40 with Schizophrenia: Results of a Pilot Study.针对40岁以上精神分裂症退伍军人的抗精神病药物依从性干预:一项试点研究的结果。
Clin Schizophr Relat Psychoses. 2009 Jan 1;24(Suppl 1):S1171. doi: 10.1016/S0924-9338(09)71404-X.
7
Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.青少年精神分裂症患者运动障碍的患病率及其与主要使用非典型抗精神病药物治疗的关系。
Eur Child Adolesc Psychiatry. 2006 Oct;15(7):371-82. doi: 10.1007/s00787-006-0544-5. Epub 2006 Apr 28.
8
Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population.辛普森-安格斯量表(SAS)在自然状态下的精神分裂症患者群体中的效度。
BMC Neurol. 2005 Mar 17;5(1):5. doi: 10.1186/1471-2377-5-5.
9
Managing antipsychotic-induced parkinsonism.处理抗精神病药物所致帕金森综合征。
Drug Saf. 1999 Mar;20(3):269-75. doi: 10.2165/00002018-199920030-00006.